tiprankstipranks
Green Future Food Hydrocolloid Marine Science Co., Ltd. (HK:1084)
:1084
Hong Kong Market
Want to see HK:1084 full AI Analyst Report?

Green Future Food Hydrocolloid Marine Science Co., Ltd. (1084) AI Stock Analysis

0 Followers

Top Page

HK:1084

Green Future Food Hydrocolloid Marine Science Co., Ltd.

(1084)

Select Model
Select Model
Select Model
Neutral 46 (OpenAI - Gpt-5.6Sol)
Rating:46Neutral
Price Target:
HK$0.62
▼(-0.48% Downside)
Action:Reiterated
Date:07/03/26
The score is held back primarily by weak financial quality in 2025—sharp margin compression and negative operating/free cash flow. Technicals are supportive due to a clear uptrend above major moving averages, but overbought momentum signals raise near-term risk. Valuation is a further constraint given the very high P/E with only modest dividend support.
Positive Factors
Revenue Rebound
The strong 2025 revenue recovery indicates renewed demand or improved sales execution. Sustaining this growth would expand the company’s customer base and improve operating leverage, although profitability must recover for the rebound to create durable shareholder value.
Negative Factors
Severe Margin Compression
The sharp decline in gross and net margins shows that revenue growth is not currently translating into proportional earnings. Persistent pressure from input costs, pricing, mix, or utilization could limit the company’s ability to rebuild durable profitability.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Rebound
The strong 2025 revenue recovery indicates renewed demand or improved sales execution. Sustaining this growth would expand the company’s customer base and improve operating leverage, although profitability must recover for the rebound to create durable shareholder value.
Read all positive factors

Green Future Food Hydrocolloid Marine Science Co., Ltd. (1084) vs. iShares MSCI Hong Kong ETF (EWH)

Green Future Food Hydrocolloid Marine Science Co., Ltd. Business Overview & Revenue Model

Company Description
Green Fresh Biotechnology Co., Ltd. operates as an investment holding entity with its core business focused on the manufacturing and distribution of hydrocolloid products for the food industry. The company's activities are organized across distinc...
How the Company Makes Money
The company primarily makes money by selling marine hydrocolloid ingredients to business customers (e.g., food processors and manufacturers) that use these inputs to improve texture, stability, and shelf life in finished products. Key revenue stre...

Green Future Food Hydrocolloid Marine Science Co., Ltd. Financial Statement Overview

Summary
Revenue rebounded strongly in 2025 (+21.3% YoY), but profitability deteriorated sharply (net margin ~0.7% vs ~6.3% in 2024) and earnings were not supported by cash. Operating cash flow turned negative (~-20.3m) and free cash flow was negative (~-45.4m), reducing confidence in earnings quality and near-term financial flexibility.
Income Statement
46
Neutral
Balance Sheet
56
Neutral
Cash Flow
28
Negative
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue904.35M988.64M1.17B1.64B1.16B
Gross Profit167.16M222.32M37.64M434.72M259.97M
EBITDA80.86M153.96M-28.75M379.20M211.36M
Net Income6.59M62.13M-85.33M199.23M103.62M
Balance Sheet
Total Assets1.63B1.57B1.54B1.89B1.70B
Cash, Cash Equivalents and Short-Term Investments108.40M120.66M84.10M43.50M139.36M
Total Debt593.10M564.77M601.97M649.27M624.50M
Total Liabilities785.53M721.67M789.49M938.99M837.68M
Stockholders Equity839.05M839.35M745.24M945.20M841.98M
Cash Flow
Free Cash Flow-45.42M62.77M84.75M-82.78M-16.41M
Operating Cash Flow-20.34M128.71M96.52M-32.19M61.11M
Investing Cash Flow-25.00M-43.75M-6.96M-51.60M-137.17M
Financing Cash Flow14.13M-37.50M-55.20M-5.01M99.46M

Green Future Food Hydrocolloid Marine Science Co., Ltd. Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price0.62
Price Trends
50DMA
0.69
Negative
100DMA
0.67
Positive
200DMA
0.65
Positive
Market Momentum
MACD
>-0.01
Negative
RSI
48.11
Neutral
STOCH
62.81
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1084, the sentiment is Neutral. The current price of 0.62 is below the 20-day moving average (MA) of 0.68, below the 50-day MA of 0.69, and below the 200-day MA of 0.65, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 48.11 is Neutral, neither overbought nor oversold. The STOCH value of 62.81 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for HK:1084.

Green Future Food Hydrocolloid Marine Science Co., Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
76
Outperform
HK$410.64M17.438.24%13.75%11.92%46.15%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
58
Neutral
HK$235.00M3.7910.28%
54
Neutral
HK$9.57B-19.89-12.23%1.60%-10.01%-129.99%
46
Neutral
HK$581.77M75.970.79%1.78%13.36%-37.89%
41
Neutral
HK$42.71M-1.69-10.16%0.04%-11.32%-0.51%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:1084
Green Future Food Hydrocolloid Marine Science Co., Ltd.
0.68
<0.01
1.05%
HK:0682
Chaoda Modern Agriculture Holdings
0.22
-0.04
-15.69%
HK:1936
Ritamix Global Limited
0.87
0.23
35.94%
HK:2419
Dekon Food And Agriculture Group Class H
60.45
-23.25
-27.78%
HK:2497
Fujing Holdings Company., Limited
0.51
-0.26
-33.55%

Green Future Food Hydrocolloid Marine Science Co., Ltd. Corporate Events

Green Fresh Biotechnology Sets Board Meeting on Interim Results and Dividend
Aug 19, 2026
Green Fresh Biotechnology Company Limited, a Cayman Islands-incorporated biotechnology firm listed in Hong Kong, is led by Chairman and CEO Chan Kam Chung together with both executive and independent non-executive directors. The company operates t...
Green Fresh Biotechnology Narrows Interim Loss on Strong Carrageenan Sales
Aug 12, 2026
Green Fresh Biotechnology has signalled a sharp narrowing of its interim net loss for the six months ended 30 June 2026, expecting a loss of RMB1.0 million to RMB4.0 million versus RMB12.07 million a year earlier. The improvement stems mainly from...
Green Fresh Sandwich Box Wins Spot on Hong Kong Green Tableware Platform
Jul 8, 2026
Green Fresh Biotechnology Company Limited has secured approval for its BOTEC-branded eco-friendly sandwich box with a transparent window to be listed on Hong Kong&#8217;s Environmental Protection Department Green Tableware Platform. The product, s...
Green Fresh Wins Shareholder Backing for All AGM Resolutions
Jun 12, 2026
Green Fresh Biotechnology Company Limited reported the outcomes of its annual general meeting held on 12 June 2026, where all resolutions proposed to shareholders were approved by poll vote. Investors endorsed the audited financial statements for ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 03, 2026